Leading-edge Masimo medical devices to be displayed at Arab Health

Masimo (NASDAQ: MASI) returns to Arab Health Jan. 28-31, the world's longest running healthcare exhibition and congress held each year in Dubai, UAE, to showcase advanced, noninvasive patient monitoring technologies – including breakthrough SET^® Measure-Through Motion pulse oximetry and rainbow^® Pulse CO-Oximetry^® – that are becoming the standard-of-care across the Middle East.

Masimo will demonstrate more than a half-dozen handheld, mobile, OR, ICU, NICU, and bedside technologies. Leading-edge Masimo medical devices on display at Arab Health include:

Radical-7^®
The 2012 Radical-7^® empowers clinicians to improve patient outcomes and reduce the cost of care in multiple ways, such as reducing blood transfusion-related costs and detecting bleeding earlier with noninvasive total hemoglobin (SpHb^®), optimizing fluid management with Pleth Variability Index (PVI^®), and enabling reliable detection of respiratory depression with acoustic respiration rate (RRa™).

Masimo rainbow^® technology allows clinicians to noninvasively measure multiple blood, fluid, and ventilation parameters that previously required invasive or complicated procedures, including SpHb^®, oxygen content (SpOC™), carboxyhemoglobin (SpCO^®), methemoglobin (SpMet^®), PVI^®, and RRa™, along with Masimo SET^® Measure-Through Motion and low perfusion pulse oximetry for oxygen saturation (SpO2), pulse rate, and perfusion index (PI). With touch, drag, and drop functionality, clinicians can move, expand, or collapse any parameter on screen for real-time analysis. Standard wireless connectivity in the handheld Radical-7^® keeps patients connected even when moving from the OR, to critical care areas, to the general floor.

Masimo Patient SafetyNet™
The Masimo Patient SafetyNet™ remote monitoring and clinician notification system combines Masimo rainbow^® Pulse CO-Oximetry™ and rainbow^® Acoustic Monitoring™ with wireless clinician notifications via pager or smartphone – providing an unmatched level of safety for up to 80 patients on four floors. Patient SafetyNet facilitates early clinical response to preempt sentinel events and avoid unnecessary ICU transfers while helping meet The Joint Commission and Anesthesia Patient Safety Foundation guidelines for patient safety.

SpfO2™
SpfO2™ is a new fractional arterial oxygen saturation parameter through the rainbow^® Universal ReSposable SuperSensor™, the first noninvasive sensor to provide simultaneous monitoring of SpHb^®, SpCO^®, SpMet^®, SpfO2™, SpOC™, Perfusion Index, PVI^®, and Measure-Through Motion and Low Perfusion SpO2 and pulse rate. Until now, pulse oximeters could only measure and display functional oxygen saturation (SpO2), so when patients had elevated carboxyhemoglobin (from carbon monoxide poisoning) and/or elevated methemoglobin (negative reaction to more than 30 common drugs used in hospitals) the displayed functional oxygen saturation overestimated the actual oxygen saturation value. SpfO2™allows more precise arterial oxygenation assessment and may allow earlier interventions and more timely therapeutic decisions. SpfO2™ is pending U.S. FDA 510(k) clearance.

Sneak Previews:
Also at the Masimo Booth, we will greet visitors with sneak-previews of new technologies for patient care.

Masimo Pronto -7^®
Masimo Pronto -7^® is a palm-sized handheld device designed for quick and easy noninvasive spot-checking of hemoglobin (SpHb^®), SpO2, pulse rate, and perfusion index at the point-of-care. Offering a breakthrough new solution for measuring hemoglobin in less than one minute – without needles, time-consuming laboratory analysis, blood contamination, hazardous medical waste, and patient discomfort associated with traditional blood tests – the Pronto-7^® puts the power of noninvasive hemoglobin spot-check measurements into clinician's hands. With dimensions of just 13 cm x 7.2 cm x 2.5 cm (5.1" x 2.8" x 1") and weight of 296 grams (10.5 ounces), Pronto-7^® offers the convenience, speed, and accuracy today's care providers need to facilitate timely assessment and treatment decisions. And embedded 802.11 b/g and Bluetooth communication capabilities make wireless printing and emailing of test results quick and easy.

"We are honored to showcase and demonstrate our latest cutting-edge, noninvasive patient monitoring innovations at Arab Health," said Masimo founder and CEO Joe Kiani . "As an increasing number of prestigious hospitals throughout the Middle East adopt Masimo SET^® pulse oximetry and rainbow^® Pulse CO-Oximetry, we are pleased to deliver our finest patient monitoring technology to this vital area of the world."